Clinical Trial Update: Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer [Phase 2]

View source ↗

Summary

Phase 2 study from the University of Michigan Rogel Cancer Center tested individualized adaptive de-escalated radiotherapy for HPV-related oropharyngeal cancer;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Cancer

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Oropharynx Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-05-22